Curing Disease from the Ground Up: How to Operate a Biotechnology Business Incubator
Block, Timothy M.
相關主題
商品描述
This operations manual offers an accessible, step-by-step guide to launching, running, and achieving success with a life science and biotechnology business incubator. Written by the founder and President Emeritus of the Pennsylvania Biotechnology Center (PABC), one of the most successful biotech and drug discovery incubators in the United States, it is designed to introduce researchers and funders to the broad considerations and minute details of managing an incubation program.
As of 2023, there are more than 1100 business incubators in the United States alone, and more than 5000 worldwide. One of the fastest-growing industries of the "new economy," science business incubators are a tool for regional economic stimulation and commercial development for universities and research organizations. The PABC was founded in 2006 as a state-of-the-art research facility; its purpose and operation is unusual and its success has been remarkable. It was created by the nonprofit Hepatitis BFoundation and its research arm, the Baruch S. Blumberg Institute, to help their effort to find a cure for hepatitis B. But it has proved to be more than a source of funding for those nonprofits - it has become a major economic driver for its region and Pennsylvania, creating thousands of jobs and bringing in billions of dollars to the local economy. The PABC's model has drawn attention from economists, legislators, and the research community. The strategy of bringing nonprofit research organizations and biotech startups under one roof was a founding principle, and has created powerful, lasting collaborations between scientific innovators, entrepreneurs and investors. The partnerships forged at the PABC have led to the discovery, testing, and FDA approval of new drugs for cancer and gastrointestinal diseases and medical devices, as well as multiple multimillion-dollar IPOs, and thousands of jobs. There are currently more than 50 startups housed in the Center's offices, ranging in focusfrom pharmaceuticals and diagnostics, to medical wearables and nanomedicine research.
Curing Disease from the Ground Up: How to Operate a Biotechnology Business Incubator tells both a personal story about the ups and downs of leveraging a business incubator to fund and find a cure for a deadly disease, as well as providing a practical guide to running a business incubator. It is a first-hand, expert perspective for running a science business incubator, and explains how the success of the PABC can be learned and replicated. Whether it is developing a mission-focused framework, the practicalities of managing a scalable, business-savvy research nonprofit, identifying ideal tenant partners, or planning for the infrastructure needs of a large research facility, this manual is the first and last stop for entrepreneurial thinkers in this field.
商品描述(中文翻譯)
這本操作手冊提供了一個易於理解的、逐步指南，以啟動、運營和實現生命科學和生物技術業務孵化器的成功。該手冊由賓夕法尼亞生物技術中心（PABC）的創始人和名譽主席撰寫，該中心是美國最成功的生物技術和藥物發現孵化器之一，旨在向研究人員和資助者介紹管理孵化計劃的廣泛考慮因素和細節。
截至2023年，僅在美國就有超過1100個業務孵化器，全球超過5000個。作為“新經濟”中增長最快的行業之一，科學業務孵化器是大學和研究機構的區域經濟刺激和商業發展工具。PABC成立於2006年，是一個先進的研究設施；它的目的和運作方式是不尋常的，其成功令人矚目。它由非營利組織乙型肝炎基金會及其研究機構巴魯克·S·布倫伯格研究所創建，旨在幫助他們尋找乙型肝炎的治愈方法。但它不僅僅是這些非營利組織的資金來源，它還成為該地區和賓夕法尼亞州的主要經濟驅動力，創造了數千個就業機會，為當地經濟帶來了數十億美元。PABC的模式引起了經濟學家、立法者和研究界的關注。將非營利研究機構和生物技術初創企業聚集在一個地方的策略是一個創立原則，並在科學創新者、企業家和投資者之間建立了強大而持久的合作關係。在PABC建立的合作夥伴關係下，已經發現、測試和獲得FDA批准的新藥物，用於治療癌症和胃腸疾病以及醫療設備，還有多個價值數百萬美元的首次公開募股，以及數千個就業機會。目前，中心辦公室內有50多家初創企業，涵蓋從制藥和診斷到醫療可穿戴設備和納米醫學研究等各個領域。
《從基礎開始治愈疾病：如何運營生物技術業務孵化器》既講述了一個關於利用業務孵化器籌集資金並尋找治愈致命疾病的曲折故事，又提供了一個運營業務孵化器的實用指南。這是一個第一手的、專家的運營科學業務孵化器的觀點，並解釋了PABC的成功如何可以被學習和複製。無論是制定以使命為中心的框架，管理可擴展的商業研究非營利組織的實際操作，確定理想的租戶合作夥伴，還是規劃大型研究設施的基礎設施需求，這本手冊是這個領域中創業思想家的首選和最後一站。
作者簡介
Timothy M. Block, Ph.D., is Visiting Professor, Yale University School of Medicine and Co-founder and President Emeritus of the Hepatitis B Foundation and its Baruch S. Blumberg Institute / Pennsylvania Biotechnology Center (2006). He is scientific co-founder of several life sciences companies, served on numerous company Boards, ranging from those that are startups to publicly traded, and helped in their raise of hundreds of millions of dollars. He is co-inventor on 20 issued patents and 23 applications, has co-authored more than 270 scholarly papers, received more than $50 million in extramural research during his career, has advised and served on numerous federal review panels (NIH, FDA, DoD). He has was tenured Professor at Thomas Jefferson University College of Medicine and Drexel University College of Medicine and continues to be an Adjunct Professor at the University of Pennsylvania School of Medicine. He has received numerous awards and honors that include named Fellow, American Association for the Advancement of Science (AAAS) and Fellow, U.S. National Academy of Inventors; Fellow of the American Association for the Study of Liver Diseases (FAASLD). special citations from the U.S. Congress and PA legislature; "Best Life Science CEO" from the Philadelphia Business Journal and PharmaVoice 100; "Researcher of the Year" from the American Liver Foundation. In 2020, he and Ms. Block received the inaugural Distinguished Public Service Award on behalf of the Hepatitis B Foundation from the AASLD. He received the Ph.D. in Microbiology from the State University of New York, Buffalo, followed by post-doctoral training in Biochemistry at Princeton University, and completed a sabbatical at the University of Oxford University.
作者簡介(中文翻譯)
Timothy M. Block, Ph.D.，是耶魯大學醫學院的客座教授，也是乙型肝炎基金會及其巴魯克·S·布倫伯格研究所/賓夕法尼亞生物技術中心（2006年）的聯合創始人和名譽主席。他是幾家生命科學公司的科學聯合創始人，曾在多家公司董事會任職，從初創公司到上市公司，並協助籌集了數億美元的資金。他是20項已獲得專利和23項申請的共同發明人，共同撰寫了270多篇學術論文，在其職業生涯中獲得了超過5000萬美元的國外研究資金，並在許多聯邦審查小組（NIH、FDA、DoD）上提供了建議和服務。他曾是托馬斯·傑斐遜大學醫學院和德雷克塞爾大學醫學院的終身教授，現在仍然是賓夕法尼亞大學醫學院的兼職教授。他獲得了許多獎項和榮譽，包括美國科學促進協會（AAAS）的名譽會士和美國國家發明家學院的會士；美國肝病研究學會（FAASLD）的會士。他還獲得了美國國會和賓夕法尼亞州議會的特別嘉獎；費城商業雜誌和PharmaVoice 100的“最佳生命科學首席執行官”；美國肝臟基金會的“年度研究員”。2020年，他和Block女士代表乙型肝炎基金會獲得了美國肝病研究學會頒發的首屆杰出公共服務獎。他在紐約州立大學水牛城分校獲得了微生物學博士學位，隨後在普林斯頓大學進行了生物化學的博士後培訓，並在牛津大學進行了一段休假期間的研究。
